Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs geared toward increasing the horizons of cytokine-based immunotherapy, especially for cancers where cure alternatives remain limited. Make use of the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/wall-street-pepe-price-pumps-following-exchange-launch-copyright-listing-next/